DNA methylation predicts response of triple-negative breast cancer to all-trans retinoic acid treatment
DNA methylation predicts response of triple-negative breast cancer to all-trans retinoic acid treatment
批准号:
368198
负责人:
Coyle Krysta M
金额:
$0.07万
依托单位国家:
加拿大
项目类别:
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-07-01 至 2018-07-01
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have identified a new approach to select breast cancer patients who will benefit from treatment with an existing drug, retinoic acid. This research will have important benefits for patients with an aggressive type of breast cancer known as triple-negat
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterizing RNA regulation in B lymphocytes
-
批准号:502601
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2024
-
负责人:Coyle Krysta M
-
依托单位:
Functional characterization of regulatory mutations in mantle cell lymphoma
-
批准号:397290
-
项目类别:Fellowship Programs
-
资助金额:$9.83万
-
财政年份:2018
-
负责人:Coyle Krysta M
-
依托单位:
Characterizing expression and function of the tumor suppressor gene RARRES1 in the differentiation hierarchy of breast cancer
-
批准号:337252
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2015
-
负责人:Coyle Krysta M
-
依托单位:
Improving the efficacy of retinoic-acid-based therapies in triple-negative breast cancer
-
批准号:317861
-
项目类别:Studentship Programs
-
资助金额:$7.65万
-
财政年份:2014
-
负责人:Coyle Krysta M
-
依托单位: